TEXAS INDUSTRY

Texas Healthcare

Psyence BioMed Invested in PsyLabs for Texas Trial

Psyence BioMed Invested in PsyLabs for Texas Trial

The firm committed $5 million and initiated a share exchange to support clinical trials for pharmaceutical-grade ibogaine.

Live Poll

Should pharmaceutical companies prioritize the development and manufacturing of experimental drugs for clinical research?


Recent news